Insider Trading & Ownership - OPIANT PHARMACEUTICALS INC. (OPNT)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for OPIANT PHARMACEUTICALS INC.
Goto Prev, 0, 1, 2
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-03-15
Sale
2021-03-17
4:53 pm
OPIANT PHARMACEUTICALS INC.OPNTMacDougall Ann L.
Director
14,155$11.35$160,67038,650
(Direct)
View
2021-03-15
Sale
2021-03-17
4:51 pm
OPIANT PHARMACEUTICALS INC.OPNTSilver Gabrielle Alison
Director
13,006$11.31$147,03735,576
(Direct)
View
2020-09-03
Purchase
2020-09-08
4:01 pm
OPIANT PHARMACEUTICALS INC.OPNTThomas Thomas T.
Director
3,000$8.3417$25,0255,000
(Direct)
View
2020-06-10
Purchase
2020-06-12
4:02 pm
OPIANT PHARMACEUTICALS INC.OPNTSilver Gabrielle Alison
Director
2,730$9.13$24,9254,515
(Direct)
View
2020-06-11
Purchase
2020-06-11
4:06 pm
OPIANT PHARMACEUTICALS INC.OPNTO'Toole David D
Chief Financial Officer
1,000$8.74$8,74015,365
(Direct)
View
2020-05-26
Purchase
2020-05-26
4:25 pm
OPIANT PHARMACEUTICALS INC.OPNTO'Toole David D
Chief Financial Officer
1,000$11$11,00014,365
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-06-15
Option Award
2021-06-16
4:07 pm
2022-06-15
2031-06-14
OPIANT PHARMACEUTICALS INC.OPNTDaly Richard J
Director
4,500$08,300
(Direct)
View
2021-06-15
Option Award
2021-06-16
4:06 pm
2022-06-15
2031-06-14
OPIANT PHARMACEUTICALS INC.OPNTMacDougall Ann L.
Director
4,500$025,679
(Direct)
View
2021-06-15
Option Award
2021-06-16
4:05 pm
2022-06-15
2031-06-14
OPIANT PHARMACEUTICALS INC.OPNTSilver Gabrielle Alison
Director
4,500$021,343
(Direct)
View
2021-06-15
Option Award
2021-06-16
4:04 pm
N/A
N/A
OPIANT PHARMACEUTICALS INC.OPNTLorianne Masuoka K.
Director
2,000$02,000
(Direct)
View
2021-06-15
Option Award
2021-06-16
4:01 pm
2022-06-15
2031-06-14
OPIANT PHARMACEUTICALS INC.OPNTCollard Craig A
Director
4,500$06,500
(Direct)
View
2021-05-13
Exercise
2021-05-13
4:10 pm
N/A
N/A
OPIANT PHARMACEUTICALS INC.OPNTSilver Gabrielle Alison
Director
365$1016,843
(Direct)
View
2021-05-13
Exercise
2021-05-13
4:10 pm
N/A
2021-05-16
OPIANT PHARMACEUTICALS INC.OPNTSilver Gabrielle Alison
Director
365$016,843
(Direct)
View
2021-05-13
Exercise
2021-05-13
4:06 pm
N/A
2021-05-16
OPIANT PHARMACEUTICALS INC.OPNTMacDougall Ann L.
Director
341$1021,179
(Direct)
View
2021-03-18
Option Award
2021-03-22
4:10 pm
N/A
2031-03-17
OPIANT PHARMACEUTICALS INC.OPNTLorianne Masuoka K.
Director
5,000$05,000
(Direct)
View
2021-03-15
Exercise
2021-03-17
4:53 pm
N/A
2021-05-16
OPIANT PHARMACEUTICALS INC.OPNTMacDougall Ann L.
Director
15,993$1038,650
(Direct)
View
2021-03-15
Exercise
2021-03-17
4:51 pm
N/A
2021-05-16
OPIANT PHARMACEUTICALS INC.OPNTSilver Gabrielle Alison
Director
14,635$1035,576
(Direct)
View
2021-03-05
Exercise
2021-03-08
4:02 pm
N/A
N/A
OPIANT PHARMACEUTICALS INC.OPNTSilver Gabrielle Alison
Director
8,334$1029,849
(Direct)
View
2021-03-05
Exercise
2021-03-08
4:02 pm
N/A
2021-05-16
OPIANT PHARMACEUTICALS INC.OPNTSilver Gabrielle Alison
Director
8,334$029,849
(Direct)
View
2021-02-11
Exercise
2021-02-16
4:01 pm
N/A
2021-05-16
OPIANT PHARMACEUTICALS INC.OPNTMacDougall Ann L.
Director
7,000$1035,334
(Direct)
View
2021-01-26
Option Award
2021-01-27
4:23 pm
N/A
2031-01-26
OPIANT PHARMACEUTICALS INC.OPNTCRYSTAL ROGER
Chief Executive Officer
10% Owner
50,666$072,791
(Direct)
View
2021-01-26
Option Award
2021-01-27
4:20 pm
N/A
2031-01-26
OPIANT PHARMACEUTICALS INC.OPNTO'Toole David D
Chief Financial Officer
18,600$033,965
(Direct)
View
2021-01-26
Option Award
2021-01-27
4:17 pm
N/A
2031-01-26
OPIANT PHARMACEUTICALS INC.OPNTEllison Mark Jason Heath
Chief Development Officer
18,386$018,386
(Direct)
View
2021-01-26
Option Award
2021-01-27
4:13 pm
N/A
2031-01-26
OPIANT PHARMACEUTICALS INC.OPNTSkolnick Phil
Chief Scientific Officer
18,948$023,098
(Direct)
View
2021-01-26
Option Award
2021-01-27
4:09 pm
N/A
2031-01-26
OPIANT PHARMACEUTICALS INC.OPNTGorman Brian
General Counsel
17,524$031,024
(Direct)
View
2020-07-10
Other(A)
2020-07-13
4:59 pm
N/A
N/A
OPIANT PHARMACEUTICALS INC.OPNTSinclair Michael
Director
10% Owner
2,000$071,220
(Direct)
View
2020-06-15
Option Award
2020-06-15
4:19 pm
N/A
N/A
OPIANT PHARMACEUTICALS INC.OPNTSinclair Michael
Director
10% Owner
2,000$071,220
(Direct)
View
2020-06-15
Option Award
2020-06-15
4:16 pm
2021-06-15
2030-06-15
OPIANT PHARMACEUTICALS INC.OPNTDaly Richard J
Director
4,500$06,300
(Direct)
View
2020-06-15
Option Award
2020-06-15
4:13 pm
2021-06-15
2030-06-15
OPIANT PHARMACEUTICALS INC.OPNTSilver Gabrielle Alison
Director
4,500$09,015
(Direct)
View
2020-06-15
Option Award
2020-06-15
4:10 pm
2021-06-15
2030-06-15
OPIANT PHARMACEUTICALS INC.OPNTThomas Thomas T.
Director
4,500$04,500
(Direct)
View
2020-06-15
Option Award
2020-06-15
4:07 pm
2021-06-15
2030-06-15
OPIANT PHARMACEUTICALS INC.OPNTMacDougall Ann L.
Director
4,500$014,500
(Direct)
View
2020-06-15
Option Award
2020-06-15
4:05 pm
2021-06-15
2030-06-15
OPIANT PHARMACEUTICALS INC.OPNTCollard Craig A
Director
4,500$04,500
(Direct)
View

Ownership
2020-06-03
4:02 pm
N/A
N/A
OPIANT PHARMACEUTICALS INC.OPNTGorman Brian
General Counsel
0$050,000
(Direct)
View
(A) Indicate amendment filing.
Goto Prev, 0, 1, 2